Grants for Public Housing Authorities

The "NCI National Clinical Trials Network - Network Lead Academic Participating Sites" grant is a funding opportunity from the National Cancer Institute for academic centers to provide scientific leadership and patient recruitment for large-scale, multi-institutional cancer clinical trials, with a focus on treatment trials, rare cancers, and underserved populations, offering up to $1.7 million per year for a six-year project period.

This funding opportunity supports researchers investigating new biological, environmental, and social factors contributing to liver cancer in the U.S., particularly in relation to established risk factors and health disparities.

This funding opportunity is designed for researchers with active NCI R01 grants to validate and enhance existing cancer biomarker assays, facilitating their clinical use and improving cancer detection and treatment strategies.

This funding opportunity supports ongoing clinical trials aimed at improving the diagnosis, prevention, and treatment of dental, oral, and craniofacial diseases, encouraging applications from a wide range of eligible institutions and organizations.

This funding opportunity provides financial support to the American College of Radiology to establish a center that will enhance radiotherapy and imaging services for clinical trials in cancer research across the National Clinical Trials Network.

The "Single Source: NCI National Clinical Trials Network - Canadian Collaborating Clinical Trials Network" grant is a $3.8 million funding opportunity from the National Institutes of Health, specifically for Queen’s University at Kingston, to support its collaboration with the U.S. in conducting large-scale, multi-site clinical trials for innovative cancer treatments, while ensuring regulatory compliance and efficient data management.

This funding opportunity supports U.S. institutions and organizations in developing centers that integrate advanced translational science into cancer clinical trials, enhancing research on precision medicine and rare cancers.

The "Epidemiologic Research on Emerging Risk Factors and Liver Cancer Susceptibility" grant is a funding opportunity by the National Cancer Institute for research projects that aim to investigate new and existing risk factors of liver cancer, including biological, environmental, and social factors, to enhance understanding of the disease and inform prevention strategies in the U.S.

The "Limited Competition: NCI National Clinical Trials Network - Network Group Statistics and Data Management Centers" grant is designed to provide financial support to current awardees for maintaining centers that offer statistical expertise and data management for large-scale, multi-center oncology clinical trials aimed at advancing cancer treatment through precision medicine approaches.

This funding opportunity supports research projects that investigate individual differences in pain experiences and treatment responses, aiming to develop personalized pain management strategies while addressing the opioid crisis.

The "Identify and Evaluate Potential Risk Factors for Amyotrophic Lateral Sclerosis (ALS)" grant is a $2.5 million funding opportunity from the CDC and ATSDR, aimed at supporting research to better understand potential risk factors for ALS, with a focus on environmental and occupational exposures, military service, traumatic brain injury, neuroinflammation, contact sports, and infectious agents, especially in underrepresented populations.

This program provides funding to publicly owned wastewater treatment plants to upgrade their systems for better nitrogen removal, improving water quality in the Chesapeake Bay watershed.

This funding opportunity supports neurologists and neurosurgeons in the NINDS intramural program as they transition to independent research-focused faculty positions at academic institutions.

This grant provides funding to local governments and nonprofit organizations in Tulsa to create and improve affordable housing options for low and moderate-income families.

This program provides substantial funding to support the development of commercial, cultural, industrial, and mixed-use projects in Chicago, aimed at enhancing community infrastructure and services.

This funding opportunity supports research projects that combine imaging techniques and liquid biopsies to improve cancer treatment monitoring and response assessment in clinical settings.

This funding opportunity provides financial support to nonprofit organizations and public agencies in Vancouver, Washington, to develop new or enhanced services that help reduce poverty, prevent homelessness, and improve housing stability for low-income individuals and families.

This funding opportunity supports the establishment of research centers that create advanced animal models for studying diseases, enabling better translation of genetic research into human health applications, and is open to a variety of eligible institutions and organizations.

This funding opportunity provides financial support for U.S.-based researchers and institutions to develop innovative human models that simulate radiation injuries, aiming to improve understanding and treatment of radiation exposure effects.

This funding opportunity supports researchers new to the field of chemical-induced skin injury, providing resources to investigate the effects of toxic chemicals on skin and develop potential medical countermeasures.